Belite Bio Cash Flow Statement (2020-2025) | BLTE

Cash Flow Statement Dec2020 Dec2021 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income (Quarter) -2.39B-2.40B-0.01B-6.89B-6.81B-0.01B-0.01B-7.87B-9.49B-8.67B-10.10B-14.28B-16.32B-21.69B-25.32B
Depreciation and Depletion (Quarter) 0.00B0.00B
Share-based Compensation (Quarter) 0.00B0.01B
Gains from Sales and Divestitures (Quarter) 0.00B
Gains from Investment Securities (Quarter) 0.00B0.00B0.00B0.00B-0.00B-0.00B
Non-cash Items (Quarter) 0.01B0.00B0.01B0.03B0.27B0.00B
Cash from Operations (Quarter) -0.00B-0.01B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.00B0.00B
Depreciation & Amortization (CF) (Quarter) 0.00B0.00B
Change in Working Capital
Change in Account Payables (Quarter) -0.00B-0.00B
Change in Accured Expenses (Quarter) 0.00B0.00B0.00B0.01B0.00B
Investing Activities
Capital Expenditures (Quarter) 0.00B
Change in Intangibles (Quarter) 0.00B
Change in Acquisitions & Divestments (Quarter) 0.04B0.05B
Cash from Investing Activities (Quarter) -0.03B-0.30B
Financing Activities
Cash from Financing Activities (Quarter) 0.04B0.51B
Additional items
Exchange Rate Effect (Quarter) -0.00B-0.00B
Change in Cash (Quarter) 0.01B0.20B
Free Cash Flow (Quarter) -0.00B-0.01B
Net Cash Flow (Quarter) 0.01B0.20B